Filter articles using the following links

GenSight Biologics to Host KOL Event on June 12, 2018 in New York City

15th Gilbert Dupont Healthcare Conference, Paris, France

GenSight Biologics to Present Data on GS010 and GS030 at the Annual Meeting of ARVO

GenSight Biologics reports €49 million cash position as of March 31, 2018 and provides update on GS010

ISCAS 2018, Florence, Italy

21st Annual Meeting ASGCT, Chicago (IL), US

GenSight Biologics announces topline results from REVERSE Phase III clinical trial of GS010 in patients with Leber Hereditary Optic Neuropathy (LHON)

ARVO Annual Meeting, Honolulu, Hawaï, US

BioEurope Spring, Amsterdam, The Netherlands

44th NANOS, Hawaii, The Big Island, US